Ligand Pharmaceuticals
LGND
#4062
Rank
โ‚น194.70 B
Marketcap
โ‚น10,304
Share price
1.11%
Change (1 day)
124.50%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): โ‚น128.21

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น132.52. In 2022 the company made an earnings per share (EPS) of -โ‚น167.13 a decrease over its 2021 EPS that were of โ‚น292.05.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น128.21-176.71%
2022-โ‚น167.13-157.23%
2021โ‚น292.05-2571.43%
2020-โ‚น11.82-100.46%
2019โ‚น2,584353.48%
2018โ‚น569.751025%
2017โ‚น50.64-700%
2016-โ‚น8.44-100.87%
2015โ‚น975.741859.32%
2014โ‚น49.805.36%
2013โ‚น47.278.0704505322479E+18%
2012โ‚น0.0000000000-100%
2011โ‚น41.36-194.23%
2010-โ‚น43.89548.38%
2009-โ‚น6.77-98.7%
2008-โ‚น521.63-136.52%
2007โ‚น1,428-787.8%
2006-โ‚น207.64-14.58%
2005-โ‚น243.09-21.31%
2004-โ‚น308.93-55.15%
2003-โ‚น688.7681.33%
2002-โ‚น379.832.74%
2001-โ‚น369.70-45.93%
2000-โ‚น683.70-14.56%
1999-โ‚น800.18-45.52%
1998-โ‚น1,469-3.97%
1997-โ‚น1,529132.31%
1996-โ‚น658.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,194 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น30.39-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น295.49 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น153.76 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น157.00 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น458.27 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น335.10 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น432.16 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,189 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA